FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q92871876> ?p ?o ?g. }

• Q92871876 description "2019 nî lūn-bûn" @default.
• Q92871876 description "2019年の論文" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年学术文章" @default.
• Q92871876 description "2019年學術文章" @default.
• Q92871876 description "2019年學術文章" @default.
• Q92871876 description "2019年學術文章" @default.
• Q92871876 description "2019年學術文章" @default.
• Q92871876 description "2019年學術文章" @default.
• Q92871876 description "2019년 논문" @default.
• Q92871876 description "article científic" @default.
• Q92871876 description "article scientific" @default.
• Q92871876 description "article scientifique" @default.
• Q92871876 description "articol științific" @default.
• Q92871876 description "articolo scientifico" @default.
• Q92871876 description "artigo científico" @default.
• Q92871876 description "artigo científico" @default.
• Q92871876 description "artigo científico" @default.
• Q92871876 description "artikel ilmiah" @default.
• Q92871876 description "artikull shkencor" @default.
• Q92871876 description "artikulong pang-agham" @default.
• Q92871876 description "artykuł naukowy" @default.
• Q92871876 description "artículo científico publicado en 2019" @default.
• Q92871876 description "artículu científicu" @default.
• Q92871876 description "bilimsel makale" @default.
• Q92871876 description "bài báo khoa học" @default.
• Q92871876 description "naučni članak" @default.
• Q92871876 description "scienca artikolo" @default.
• Q92871876 description "scientific article published on 23 August 2019" @default.
• Q92871876 description "scientific article published on 23 August 2019" @default.
• Q92871876 description "scientific article published on 23 August 2019" @default.
• Q92871876 description "teaduslik artikkel" @default.
• Q92871876 description "tieteellinen artikkeli" @default.
• Q92871876 description "tudományos cikk" @default.
• Q92871876 description "vedecký článok" @default.
• Q92871876 description "vetenskaplig artikel" @default.
• Q92871876 description "videnskabelig artikel udgivet 23. august 2019" @default.
• Q92871876 description "vitenskapelig artikkel" @default.
• Q92871876 description "vitskapeleg artikkel" @default.
• Q92871876 description "vědecký článek" @default.
• Q92871876 description "wetenschappelijk artikel" @default.
• Q92871876 description "wissenschaftlicher Artikel" @default.
• Q92871876 description "επιστημονικό άρθρο" @default.
• Q92871876 description "мақолаи илмӣ" @default.
• Q92871876 description "наукова стаття, опублікована в серпні 2019" @default.
• Q92871876 description "научна статия" @default.
• Q92871876 description "научная статья" @default.
• Q92871876 description "научни чланак" @default.
• Q92871876 description "научни чланак" @default.
• Q92871876 description "מאמר מדעי" @default.
• Q92871876 description "مقالة علمية نشرت في 23 أغسطس 2019" @default.
• Q92871876 description "২৩ আগস্ট ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q92871876 description "บทความทางวิทยาศาสตร์" @default.
• Q92871876 description "სამეცნიერო სტატია" @default.
• Q92871876 name "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 name "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 type Item @default.
• Q92871876 label "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 label "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 prefLabel "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 prefLabel "Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial" @default.
• Q92871876 P1433 Q92871876-B9246DA3-1713-4540-9815-937D8600895A @default.
• Q92871876 P1476 Q92871876-5D9BB2F8-3A45-482C-816B-B016FE0B1B10 @default.
• Q92871876 P2093 Q92871876-003FAA74-4C9A-4B29-AE94-572DFD71243B @default.
• Q92871876 P2093 Q92871876-03FD91D1-A750-4552-BE64-9132F4A44604 @default.
• Q92871876 P2093 Q92871876-0A6DD55E-800C-45FA-89AE-9AD1D3C59ABD @default.
• Q92871876 P2093 Q92871876-1952A2FD-F51B-48F0-9302-E951819185C5 @default.
• Q92871876 P2093 Q92871876-1E6FE57D-9639-441B-BBD2-7161751EE505 @default.
• Q92871876 P2093 Q92871876-48B9F510-A237-48D0-9416-232CC3CBB2CC @default.
• Q92871876 P2093 Q92871876-4AD929D2-5C6B-4588-BF80-E6CD210FC7B7 @default.
• Q92871876 P2093 Q92871876-6081488D-3316-4CAF-990C-CF6D1369D67E @default.
• Q92871876 P2093 Q92871876-8AC65E28-4559-4C47-A6A6-03462D2AB89C @default.
• Q92871876 P2093 Q92871876-8CB85BB1-72F2-4523-903A-960E739FE735 @default.
• Q92871876 P2093 Q92871876-9D8A7E9B-69D8-4275-AFBC-980BE3FAA9C9 @default.
• Q92871876 P2093 Q92871876-9F2A5637-E668-48BA-AE54-74C44A00F82A @default.
• Q92871876 P2093 Q92871876-DF718A37-5F51-4659-AE58-E9254B0FDBAB @default.
• Q92871876 P2093 Q92871876-DFAA9A1C-CCB8-4020-8544-F9C8DA053637 @default.
• Q92871876 P2093 Q92871876-DFC0249E-8C99-45ED-9B60-59AC104FC2D3 @default.
• Q92871876 P2093 Q92871876-E66AB8BE-A5C9-46F8-89DC-5A0DD32D488E @default.
• Q92871876 P2093 Q92871876-E7F51745-EB27-4B33-98C4-28A326C2A82A @default.
• Q92871876 P2093 Q92871876-F7121645-0510-4721-8C88-864A62EF6F9D @default.
• Q92871876 P2093 Q92871876-F94E566E-7428-4213-86D5-2A18D50FAAD6 @default.
• Q92871876 P304 Q92871876-6C5D1569-D549-45DC-97E9-D3EAC125BC38 @default.
• Q92871876 P31 Q92871876-961D45DF-1DF6-4C6D-8484-E772967FED2D @default.
• Q92871876 P356 Q92871876-5AE6EB2B-1A9D-4D9F-8523-B3F54A8708F1 @default.
• Q92871876 P478 Q92871876-1401BA21-C849-4EED-8AD9-90B1A27B5694 @default.
• Q92871876 P50 Q92871876-61630C9C-72C2-4CBC-9F2A-1422E800B23D @default.
• Q92871876 P50 Q92871876-6B649AF2-9D98-4B93-8725-D891533E70D9 @default.
• Q92871876 P50 Q92871876-EAD3DD30-11F9-4220-8AB7-B07512C65BE6 @default.
• Q92871876 P577 Q92871876-28231990-29DB-4728-8B19-1495CF0E6A6F @default.
• Q92871876 P698 Q92871876-F60F38FB-193F-456E-A357-95A194D19730 @default.
• Q92871876 P921 Q92871876-93F7BFD2-224D-4FC7-B80A-F9FFD6619A33 @default.
• Q92871876 P921 Q92871876-BA62D45A-2CDE-4A11-B95B-3A7CFF68616D @default.
• Q92871876 P356 J.ORALONCOLOGY.2019.08.004 @default.
• Q92871876 P698 31450171 @default.
• Q92871876 P1433 Q7099367 @default.

• next